Member Info for mulledwine

Anyone now of reason for drop?...no RNS with info

http://www.investegate.co.uk/Article.aspx?id=201007280727220477Q

Antisoma plc Notification of Preliminary Results London, UK, and Cambridge, MA: 20 July 2010 - Antisoma plc (LSE: ASM; USOTC: ATSMY) will be announcing its Preliminary Results for the year ended 30 June 2010 on Thursday 29 July 2010.

Any followers of this share can enlighten me as to reason for continued drop?

Hmmmm - contary to previous post there do appear to have been issues.I will need to dig deaper as they say!

Just started looking at this share ...seems to have fallen from grace re SP....will research to find out why - but any easy offers of an answer are welcomed lol...but a quick 5 minute look indicates the SP should surely be higher.

http://www.jetion.com.cn/docs/aim/10051874-Jetion-ar(e).pdf

Howdy again kline - yup I think this has potential from here - 2 good products in the pipeline.... just hope the trials continue to be positive and this will rise well up from herer - one piece of bad news tho and it will be carnage - you never know with the pharma's but I really think its worth a punt. GLA

http://www.investegate.co.uk/Article.aspx?id=20100621070000H5436 Another presentation - they are certainly trying to reclaim lost confidence by pushing themselves forward whenever they can!

In auction...interesting times!

http://www.pr-inside.com/antisoma-announces-presentation-at-asco-of-new-dat-r1931830.htm

I missed this broker backing so I post it incase anyone else did too ! --- LONDON (SHARECAST) - Cancer drug developer Antisoma is continuing its share price recovery following a buy recommendation from broker KBC Peel Hunt. The broker believes that the upside in the shares could be considerable if there is positive news from two cancer drug trials over the next 12 months. The AS1413 phase III study for secondary acute myeloid leukaemia is due to be published in the first half of 2011 and the phase IIb study of AS1411 for acute myeloid leukaemia and renal cell carcinoma should be reported on at around the same time. A commercial partner for either drug could further boost the share price. The company’s cash should last until late 2011.

bigenglish - good to see Admin also thought your post was out of order and you have been deleted yet again. No one minds negative comments as long as they are informative and factual....if you have legitimate reasons for downing this Company then lets hear them. Im sure we would all be genuinely interested but not in wild unfounded accusations.

bigenglish AKA - thenuts(banned) after slanderous remarks on this chat board - I see you are back with your slanderous remarks about this Company killing people!....you obviously have a grudge with the Company however you really should be carfeul with what you insinuate

+28% - Is no one else watching this today !...break even now so Im pleased!

+14% - now thats more like it - should go much higher over next couple of weeks - that was a good latest RNS - for those not in here you should read it!

Nice rise today and in auction I think

http://www.investegate.co.uk/Article.aspx?id=20100606210000H1817

We always have the security blanket of the directors buys at 7.5 to soothe our worries - however it is frustrating that it is virtually impossible to depict the low and get in then...well I always miss it anyway!

aNY IDEAS AS TO WHY THE SUDDEN TURNAROUND AND DROP - DOWN 12%+ AS I TYPE....CANT SEE ANY NEWS UNLESS IT SOMETHING TO DO WITH THE HEALTH CARE CONFERENCE IN NEW YORK ON 27TH.